http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-538337-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
filingDate | 2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750fef0ac6c78b3a6fd0bb85cac6eea3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d24ef0e4926654224e79492f4ad0d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8745b458840a283d2261930ef6c75f41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b62275d34a7526277bfb7510863d0c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1468caa7dcce2cc9feef90340372760 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e36b6f1cdf5f9a1c271ab664dd346c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f35dc6fcfa6f125c5df12fe29fe6b35 |
publicationDate | 2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-538337-A |
titleOfInvention | Indolinone derivatives substituted in position 6, production and use thereof as medicaments for treating abnormal cell proliferation |
abstract | Disclosed herein are indoline or indolinone derivatives substituted in position 6 of general formula (I), wherein R1 to R6 and X are as defined in the specification, the tautomers, enantiomers thereof, the mixtures and salts thereof, especially physiologically compatible salts which have valuable pharmaceutical properties, especially an inhibiting effect on various receptor tyrosine kinases and on the proliferation of endothelial cells and various tumor cells, medicaments containing these compounds, the use thereof and a method for the production thereof. |
priorityDate | 2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1482.